Annika Dufour

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Klaus H. Metzeler, Tobias Herold, Maja Rothenberg‐Thurley et al. · Blood · 2016 · 534 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome

Annika Dufour, Friederike Schneider, Klaus H. Metzeler et al. · Journal of Clinical Oncology · 2009 · 293 citations · Full text

Life Sciences, Genetics, Hematology +17

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

Tobias Herold, Maja Rothenberg‐Thurley, Victoria V. Grunwald et al. · Leukemia · 2020 · 191 citations · Full text

Life Sciences, Genetics, Hematology +10

GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia

Philipp A. Greif, Annika Dufour, Nikola P. Konstandin et al. · Blood · 2012 · 147 citations

Life Sciences, Genetics, Molecular Genetics +16

<i>ERG</i> Expression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis of <i>ERG, MN1</i>, and <i>BAALC</i> Transcript Levels Using Oligonucleotide Microarrays

Klaus H. Metzeler, Annika Dufour, Tobias Benthaus et al. · Journal of Clinical Oncology · 2009 · 130 citations · Full text

Medicine, Molecular Genetics, Oncology +14